시장보고서
상품코드
1428330

세계의 폐경후 골다공증 치료 시장 리포트(2024년)

Postmenopausal Osteoporosis Treatment Global Market Report 2024

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 175 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

폐경후 골다공증 치료 시장 규모는 향후 수년간 대폭적인 성장이 전망됩니다. 2028년에는 5.4%의 연간 복합 성장률(CAGR)로 123억 8,000만 달러로 성장할 것으로 예상됩니다. 예측 기간 중 예상되는 성장은 의료 인프라의 성장, 스크리닝 프로그램 증가, 정밀의료 접근법, 골다공증 치료에 바이오시밀러 사용, 여성 건강 프로그램의 뼈 건강에 초점을 맞춘 노력, 디지털 건강의 통합, 재생의학 접근법 모색 등 다양한 요인에 기인합니다. 등의 요인에 기인하는 것으로 보입니다. 예측 기간 중 주요 동향으로는 진단 방법의 발전, 신약 개발, 새로운 치료법, 의약품 개발을 위한 협업, 인공지능(AI)의 통합 등이 있습니다.

골다공증 유병률의 예상 증가는 폐경후 골다공증 치료제 시장의 성장을 가속할 것으로 예상됩니다. 골량 감소와 뼈 조직의 약화를 특징으로 하는 골다공증은 골절의 위험을 증가시킵니다. 폐경후 골다공증 치료는 증상 예방 또는 관리, 골절 위험 감소, 전반적인 건강 상태 개선에 중요한 역할을 합니다. Healthy Bones Australia의 보고서에 따르면 골다공증 또는 골감소증과 관련된 골절이 2021년 178,439건에서 2022년 183,105건으로 증가한 것이 밝혀지며, 효과적인 폐경후 골다공증 치료의 필요성을 강조하고 있습니다.

비만의 확산은 폐경후 골다공증 치료제 시장 확대에 기여할 것으로 예상됩니다. 과도한 체지방 축적을 특징으로 하는 비만은 건강에 악영향을 미칩니다. 폐경후 골다공증 치료는 골밀도를 개선하고 골절 위험을 줄이며 뼈의 건강을 증진시킴으로써 비만인 사람들에게 이점을 제공합니다. 영국 정부 보고서에 따르면 2021-2022년 18세 이상 인구의 25.9%가 비만인 것으로 나타나 폐경후 골다공증 치료 시장 잠재력이 매우 크다는 것을 강조하고 있습니다.

목차

제1장 주요 요약

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

  • 고인플레이션이 시장에 미치는 영향
  • 우크라이나·러시아 전쟁이 시장에 미치는 영향
  • 시장에 대한 COVID-19의 영향

제5장 세계 시장 규모와 성장

  • 시장 촉진요인·시장 억제요인
    • 시장 촉진요인
    • 시장 억제요인
  • 시장 규모와 성장 실적, 2018-2023년
  • 시장 규모와 성장 예측, 2023-2028년, 2033년

제6장 시장 세분화

  • 세계의 폐경후 골다공증 치료 시장, 약제 유형별 세분화, 실적 및 예측, 2018-2023년,2023-2028년, 2033년
  • 비스포스포네이트
  • 비타민 D3
  • 에스트로겐 아고니스트/안타고니스트
  • 호르몬 대체요법
  • 부갑상선호르몬 요법
  • 기타
  • 세계의 폐경후 골다공증 치료 시장, 투여 경로별 세분화, 실적 및 예측, 2018-2023년,2023-2028년, 2033년
  • 경구
  • 비경구
  • 기타
  • 세계의 폐경후 골다공증 치료 시장, 유통 채널별 세분화, 실적 및 예측, 2018-2023년,2023-2028년, 2033년
  • 병원 약국
  • 소매 약국
  • 기타

제7장 지역 및 국가 분석

  • 세계의 폐경후 골다공증 치료 시장, 지역별, 실적 및 예측, 2018-2023년,2023-2028년, 2033년
  • 세계의 폐경후 골다공증 치료 시장, 국가별, 실적 및 예측, 2018-2023년,2023-2028년, 2033년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

  • 폐경후 골다공증 치료 시장의 경쟁 구도
  • 폐경후 골다공증 치료 시장의 기업 개요
    • Pfizer Inc.
    • Johnson and Johnson
    • F. Hoffmann-La Roche AG
    • Merck and Co. Inc.
    • AbbVie Inc.

제31장 기타 대기업 및 혁신적 기업

  • Bayer AG
  • Novartis AG
  • Sanofi SA
  • Eli Lilly and Company
  • Amgen Inc.
  • Asahi Kasei Corporation
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan NV
  • Sandoz International GmbH
  • Fresenius Kabi AG
  • Daiichi Sankyo Company Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Inc.
  • Dr.Reddys Laboratories Ltd.

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 합병과 인수

제35장 전망과 가능성 분석

제36장 부록

KSA 24.03.20

Postmenopausal osteoporosis treatment refers to medical interventions and strategies aimed at managing and preventing bone loss and fractures in women after menopause. Postmenopausal osteoporosis is characterized by decreased bone density and an increased susceptibility to fractures due to hormonal changes after menopause.

The main types of drugs used in postmenopausal osteoporosis treatment include bisphosphonates, vitamin D3, estrogen agonists or antagonists, hormone replacement therapy, parathyroid hormone therapy, and others. Bisphosphonates, a class of medications, are commonly used to treat various bone-related conditions, with osteoporosis being a notable example. These medications can be administered through oral, parenteral, and other routes, and they are available through various distribution channels, including hospital pharmacies, retail pharmacies, and others.

The postmenopausal osteoporosis treatment market research report is one of a series of new reports from The Business Research Company that provides postmenopausal osteoporosis treatment market statistics, including postmenopausal osteoporosis treatment industry global market size, regional shares, competitors with a postmenopausal osteoporosis treatment market share, detailed postmenopausal osteoporosis treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the postmenopausal osteoporosis treatment industry. This postmenopausal osteoporosis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The postmenopausal osteoporosis treatment market size has grown strongly in recent years. It will grow from $9.49 billion in 2023 to $10.03 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The expansion observed in the historical period can be attributed to factors such as the aging population, the use of hormone replacement therapy, increased awareness of postmenopausal osteoporosis, efforts to reduce fracture risks, and the utilization of nutritional supplements.

The postmenopausal osteoporosis treatment market size is expected to see strong growth in the next few years. It will grow to $12.38 billion in 2028 at a compound annual growth rate (CAGR) of 5.4%. The anticipated growth in the forecast period can be attributed to factors such as healthcare infrastructure growth, increased screening programs, precision medicine approaches, the use of biosimilars in osteoporosis treatment, initiatives focused on bone health in women's health programs, the integration of digital health, and the exploration of regenerative medicine approaches. Major trends in the forecast period include advances in diagnostics, new drug development, emerging therapies, collaborations for drug development, and the integration of artificial intelligence (AI).

The projected increase in osteoporosis prevalence is expected to drive the growth of the postmenopausal osteoporosis treatment market. Osteoporosis, characterized by reduced bone mass and weakened bone tissue, poses an increased risk of fractures. Postmenopausal osteoporosis treatment plays a crucial role in preventing or managing the condition, reducing fracture risks, and enhancing overall health outcomes. A report from Healthy Bones Australia revealed a rise in fractures related to osteoporosis or osteopenia from 178,439 in 2021 to 183,105 in 2022, emphasizing the need for effective postmenopausal osteoporosis treatments.

The growing prevalence of obesity is anticipated to contribute to the expansion of the postmenopausal osteoporosis treatment market. Obesity, characterized by excessive body fat accumulation, negatively impacts health. Postmenopausal osteoporosis treatment offers benefits to individuals with obesity by improving bone density, reducing fracture risks, and promoting bone health. In England, a government report indicated that 25.9% of individuals aged 18 and older were obese in 2021-2022, emphasizing the significant market potential for postmenopausal osteoporosis treatments.

The growth of the postmenopausal osteoporosis treatment market is expected to be propelled by government initiatives focused on symptom management and disease treatment. These initiatives encompass policies, programs, or measures aimed at addressing specific health issues and achieving targeted goals. Notably, the Asia Pacific Consortium on Osteoporosis (APCO) introduced clinical practice guidelines in January 2021 for postmenopausal osteoporosis diagnosis, management, and screening. These guidelines, supported by government and other organizations, provide crucial information for patients' self-care and emphasize the need for monitoring and improving osteoporosis care quality.

Innovation in product offerings emerges as a prominent trend in the postmenopausal osteoporosis treatment market. Key market players are actively introducing new products to maintain their market positions. Theramex, a UK-based pharmaceutical company, launched Livogiva in January 2021, designed specifically for osteoporosis patients. This product expands the company's lineup, offering a range of treatments from prevention with calcium and vitamin D to advanced oral bisphosphonates with patient-friendly administration instructions.

Major companies in the postmenopausal osteoporosis treatment market are striving to gain a competitive edge through innovative products. Advanced bone-building medications, typically administered through injections to promote bone health and density, are a focus of development. In November 2023, Teva Pharmaceuticals Inc., a U.S-based pharmaceutical company, received FDA approval for Forteo (teriparatide injection), catering to postmenopausal women with osteoporosis at high fracture risk. The approval underscores the significance of innovative bone-building medications in treating osteoporosis in both men and women.

Major companies operating in the postmenopausal osteoporosis treatment market report are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Eli Lilly and Company, Amgen Inc., Asahi Kasei Corporation, Viatris Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz International GmbH, Fresenius Kabi AG, Daiichi Sankyo Company Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Dr.Reddys Laboratories Ltd., Hikma Pharmaceuticals PLC., Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Takeda Pharmaceutical Company Limited, Lupin Limited, Celltrion Inc., Biocon Limited, Accord Healthcare Ltd, Ligand Pharmaceuticals Incorporated, Torrent Pharmaceuticals Limited.

North America was the largest region in the postmenopausal osteoporosis treatment market in 2023. The regions covered in the postmenopausal osteoporosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the postmenopausal osteoporosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The postmenopausal osteoporosis treatment market consists of revenues earned by entities by providing screening and diagnosis, bone density testing, and risk assessment. The market value includes the value of related goods sold by the service provider or included within the service offering. The postmenopausal osteoporosis treatment market also includes sales of selective estrogen receptor modulators and osteoporosis drugs that are used for the treatment of postmenopausal osteoporosis. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Postmenopausal Osteoporosis Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on postmenopausal osteoporosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for postmenopausal osteoporosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The postmenopausal osteoporosis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Drug Type: Bisphosphonates; Vitamin D3; Estrogen Agonist Or Antagonist; Hormone Replacement Therapy; Parathyroid Hormone Therapy; Other Drug Types
  • 2) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
  • 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
  • Companies Mentioned: Pfizer Inc.; Johnson and Johnson; F. Hoffmann-La Roche AG; Merck and Co. Inc.; AbbVie Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Postmenopausal Osteoporosis Treatment Market Characteristics

3. Postmenopausal Osteoporosis Treatment Market Trends And Strategies

4. Postmenopausal Osteoporosis Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Postmenopausal Osteoporosis Treatment Market Size and Growth

  • 5.1. Global Postmenopausal Osteoporosis Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Postmenopausal Osteoporosis Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Postmenopausal Osteoporosis Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Postmenopausal Osteoporosis Treatment Market Segmentation

  • 6.1. Global Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Bisphosphonates
  • Vitamin D3
  • Estrogen Agonist Or Antagonist
  • Hormone Replacement Therapy
  • Parathyroid Hormone Therapy
  • Other Drug Types
  • 6.2. Global Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Parenteral
  • Other Routes Of Administration
  • 6.3. Global Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Other Distribution Channels

7. Postmenopausal Osteoporosis Treatment Market Regional And Country Analysis

  • 7.1. Global Postmenopausal Osteoporosis Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Postmenopausal Osteoporosis Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Postmenopausal Osteoporosis Treatment Market

  • 8.1. Asia-Pacific Postmenopausal Osteoporosis Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Postmenopausal Osteoporosis Treatment Market

  • 9.1. China Postmenopausal Osteoporosis Treatment Market Overview
  • 9.2. China Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Postmenopausal Osteoporosis Treatment Market

  • 10.1. India Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Postmenopausal Osteoporosis Treatment Market

  • 11.1. Japan Postmenopausal Osteoporosis Treatment Market Overview
  • 11.2. Japan Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Postmenopausal Osteoporosis Treatment Market

  • 12.1. Australia Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Postmenopausal Osteoporosis Treatment Market

  • 13.1. Indonesia Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Postmenopausal Osteoporosis Treatment Market

  • 14.1. South Korea Postmenopausal Osteoporosis Treatment Market Overview
  • 14.2. South Korea Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Postmenopausal Osteoporosis Treatment Market

  • 15.1. Western Europe Postmenopausal Osteoporosis Treatment Market Overview
  • 15.2. Western Europe Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Postmenopausal Osteoporosis Treatment Market

  • 16.1. UK Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Postmenopausal Osteoporosis Treatment Market

  • 17.1. Germany Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Postmenopausal Osteoporosis Treatment Market

  • 18.1. France Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Postmenopausal Osteoporosis Treatment Market

  • 19.1. Italy Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Postmenopausal Osteoporosis Treatment Market

  • 20.1. Spain Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Postmenopausal Osteoporosis Treatment Market

  • 21.1. Eastern Europe Postmenopausal Osteoporosis Treatment Market Overview
  • 21.2. Eastern Europe Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Postmenopausal Osteoporosis Treatment Market

  • 22.1. Russia Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Postmenopausal Osteoporosis Treatment Market

  • 23.1. North America Postmenopausal Osteoporosis Treatment Market Overview
  • 23.2. North America Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Postmenopausal Osteoporosis Treatment Market

  • 24.1. USA Postmenopausal Osteoporosis Treatment Market Overview
  • 24.2. USA Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Postmenopausal Osteoporosis Treatment Market

  • 25.1. Canada Postmenopausal Osteoporosis Treatment Market Overview
  • 25.2. Canada Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Postmenopausal Osteoporosis Treatment Market

  • 26.1. South America Postmenopausal Osteoporosis Treatment Market Overview
  • 26.2. South America Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Postmenopausal Osteoporosis Treatment Market

  • 27.1. Brazil Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Postmenopausal Osteoporosis Treatment Market

  • 28.1. Middle East Postmenopausal Osteoporosis Treatment Market Overview
  • 28.2. Middle East Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Postmenopausal Osteoporosis Treatment Market

  • 29.1. Africa Postmenopausal Osteoporosis Treatment Market Overview
  • 29.2. Africa Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Postmenopausal Osteoporosis Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Postmenopausal Osteoporosis Treatment Market Competitive Landscape
  • 30.2. Postmenopausal Osteoporosis Treatment Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson and Johnson
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. F. Hoffmann-La Roche AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Merck and Co. Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. AbbVie Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Postmenopausal Osteoporosis Treatment Market Other Major And Innovative Companies

  • 31.1. Bayer AG
  • 31.2. Novartis AG
  • 31.3. Sanofi SA
  • 31.4. Eli Lilly and Company
  • 31.5. Amgen Inc.
  • 31.6. Asahi Kasei Corporation
  • 31.7. Viatris Inc.
  • 31.8. Teva Pharmaceutical Industries Ltd.
  • 31.9. Mylan N.V.
  • 31.10. Sandoz International GmbH
  • 31.11. Fresenius Kabi AG
  • 31.12. Daiichi Sankyo Company Ltd.
  • 31.13. Sun Pharmaceutical Industries Ltd.
  • 31.14. Cipla Inc.
  • 31.15. Dr.Reddys Laboratories Ltd.

32. Global Postmenopausal Osteoporosis Treatment Market Competitive Benchmarking

33. Global Postmenopausal Osteoporosis Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Postmenopausal Osteoporosis Treatment Market

35. Postmenopausal Osteoporosis Treatment Market Future Outlook and Potential Analysis

  • 35.1 Postmenopausal Osteoporosis Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Postmenopausal Osteoporosis Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Postmenopausal Osteoporosis Treatment Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제